Aktis Oncology

AKTSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.730 B

$24.13 +2.94%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

53,403,173

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#70Legend BiotechLEGN$3.85B
#71Structure TherapeuticsGPCR$3.78B
#72Aktis OncologyAKTS$3.73B
#73Arcus BiosciencesRCUS$3.64B
#74IDEAYA BiosciencesIDYA$3.57B

Where these numbers come from

Share counts and financials for Aktis Oncology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.